[HTML][HTML] Interactions of multidomain pro-apoptotic and anti-apoptotic proteins in cancer cell death

A Chota, BP George, H Abrahamse - Oncotarget, 2021 - ncbi.nlm.nih.gov
Cancer is a global public health concern that is characterized by the uncontrolled growth of
tumor cells. It is regarded as the subsequent cause of death after cardiovascular disease …

The Bcl-2 apoptotic switch in cancer development and therapy

JM Adams, S Cory - Oncogene, 2007 - nature.com
Impaired apoptosis is both critical in cancer development and a major barrier to effective
treatment. In response to diverse intracellular damage signals, including those evoked by …

Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies

A Razaghi, K Heimann, PM Schaeffer, SB Gibson - Apoptosis, 2018 - Springer
Cancer is a primary cause of human fatality and conventional cancer therapies, eg,
chemotherapy, are often associated with adverse side-effects, tumor drug-resistance, and …

Life in the balance: how BH3-only proteins induce apoptosis

SN Willis, JM Adams - Current opinion in cell biology, 2005 - Elsevier
BH3-only members of the Bcl-2 intracellular protein family, which include Bim, Bmf, Bik, Bad,
Bid, Puma, Noxa and Hrk, mediate many developmentally programmed and induced …

[HTML][HTML] Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme

PF Cartron, D Loussouarn, M Campone… - Cell death & …, 2012 - nature.com
Apoptosis has a crucial role in anti-cancer treatment. The proteins of the BCL-2 family are
core members of the apoptotic program. Thus, we postulated that alterations in the …

Molecular determinants of Bim (BH3) peptide binding to pro-survival proteins

L Delgado-Soler, M Pinto, K Tanaka-Gil… - Journal of Chemical …, 2012 - ACS Publications
Proteins of the Bcl-2 family regulate apoptosis through the formation of heterodimers
between antiapoptotic or pro-survival proteins and proapoptotic or pro-death proteins …

Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment

PF Cartron, P Juin, L Oliver, K Meflah… - Expert review of …, 2003 - Taylor & Francis
The cell death program, apoptosis, is currently viewed as the ultimate obstacle in cancer
therapy. Inhibition of apoptosis is thought to be involved in both tumorigenesis and …

Controlling the cell death mediators Bax and Bak: puzzles and conundrums

JI Fletcher, DCS Huang - Cell cycle, 2008 - Taylor & Francis
In spite of the available genetic, biochemical and structural data, precisely how the initiators
of apoptosis, the BH3-only proteins, trigger Bax and Bak to cause organellar damage …

Apoptosis: molecular mechanisms and pathogenicity

RP Rastogi, RP Sinha - 2010 - 129.217.131.68
Apoptosis triggered by exogenous and endogenous stimuli such as ultraviolet radiation,
oxidative stress, and genotoxic chemicals is a crucial phenomenon within biological …

Prognostic impact of bim, puma, and noxa expression in human colon carcinomas

FA Sinicrope, RL Rego, K Okumura, NR Foster… - Clinical Cancer …, 2008 - AACR
Purpose: Proapoptotic BH3-only proteins (Bim, Bad, Bid, Puma, and Noxa) initiate apoptosis
by binding to regulatory sites on antiapoptotic Bcl-2 proteins, directly neutralizing their …